Metronidazolo S.A.L.F.

Metronidazole, the active ingredient in Metronidazolo S.A.L.F., is a Nitroimidazole antibiotic presented as an intravenous formulation for systemic use. It is employed to treat a range of anaerobic bacterial and protozoal infections in adult patients, including bacterial vaginosis, pelvic inflammatory disease, and gastrointestinal parasitic diseases.

GNH USA supplies Metronidazolo S.A.L.F. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole is used to manage infections caused by anaerobic bacteria and susceptible protozoa.

- Anaerobic bacterial infections: eradicates the causative anaerobes and resolves infection. - Bacterial vaginosis: restores normal vaginal flora by eliminating overgrowth of anaerobes. - Pelvic inflammatory disease: treats mixed anaerobic infections of the upper genital tract. - Trichomoniasis: eliminates Trichomonas vaginalis, relieving symptoms. - Giardiasis: clears Giardia lamblia from the intestinal tract. - Amebiasis: destroys Entamoeba histolytica trophozoites, preventing disease progression.

Metronidazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Headache: occasional throbbing headache. - Dizziness: light‑headedness or vertigo. - Abdominal pain: cramping or discomfort. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Seizures: rare neurologic events. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: anaphylaxis, rash, or swelling. - Stevens‑Johnson syndrome: severe skin blistering. - Hepatic toxicity: elevated liver enzymes or hepatitis. - Neutropenia: reduced white blood cell count.

Before initiating therapy, consider the following safety measures.

- Renal function assessment: adjust use in impaired kidneys. - Hepatic monitoring: watch for liver enzyme elevations. - Alcohol avoidance: risk of disulfiram‑like reaction. - Pregnancy caution: evaluate risk‑benefit, limited data available. - CNS disorders: use carefully in patients with seizures or neuropathy. - Store at ambient temperature: keep in original container, protect from moisture and light.

Metronidazole can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, nausea, and tachycardia. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: may raise lithium levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: can increase metronidazole plasma concentrations. - Oral contraceptives: may reduce contraceptive efficacy, consider backup method.